Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532150 | NSE Symbol : INDRAMEDCO | ISIN : INE681B01017 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
21-Jan-2025	03-Feb-2025	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve Meeting of the Board of the Directors of the company will be held on Monday 3rd February 2025 to consider and approve the un-audited financial results for the quarter ended 31th December 2024. The board of Director of the company has, as its meeting held on Monday, 3rd February, 2025, inter-alia, considered and approved the Un-audited Financial Results of the company for the quarter & nine months ended 31st December, 2024, along with Limited Review Report of the Statutory auditors. We are enclosing herewith un-audited financial results along with limited review report. (As Per BSE Announcement dated on 03.02.2025)
21-Oct-2024	30-Oct-2024	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Wednesday 30th October 2024 inter-alia to consider and approve the unaudited financial results for the quarter ended 30th September 2024. THE BOARD OF DIRECTOR EETING HELD ON TODAY I.E., 30TH OCTOBER, 2024, HAS CONSIDERED AND APPROVED THE UN-AUDITED FINANCIAL RESULTS FOR HE QUATER ENDED 30TH SEEPTEMBER, 2024.WE ARE EN-CLOSING HEREWITH UNAUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT BY THE AUDITORS (As per BSE Announcement Dated on 30/10/2024)
24-Jul-2024	05-Aug-2024	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve A meeting of the Board of Directors of the company will be held on 05-08-2024 inter-alia to consider and approve the unaudited financial results for the quarter ended 30th June 2024. we are enclosing herewith unaudited financial results for the quarter ended as approved by the board of directors at their meeting held today that is 05-08-2024. the board meeting ended at 5:45pm (As Per BSE Announcement dated on 05.08.2024)
09-May-2024	17-May-2024	Final Dividend	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday 17th May 2024 inter alia- a) to consider and approve the audited financial results for the quarter/year ended 31st March 2024 b) to consider and recommend dividend if any on equity shares of the Company for the Financial year 2023-24. The Board of Directors of the Company at its meeting held on 17th May, 2024 i.e. today, interalia: 1. Approved audited financial statements for the year ended 31st March, 2024; and 2. Recommended a dividend @45% i.e. Rs. 4.50 per share for the financial year 2023-24. Details are given in the enclosed letter. Read less.. (As Per BSE Announcement Dated on 17.05.2024)
05-Mar-2024	07-Mar-2024	Change in Directors	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2024 inter alia to consider and approve the appointment of an Independent Director on the Board of Directors of the Company. This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 7th March, 2024 (i.e. today), inter-alia, considered and appointed Mr. Tejpreet Singh Chopra (DIN 00053597) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2024 to 31st March, 2029, subject to the approval of Shareholders. The Board meeting commenced at 3.00 p.m. and ended at 4.30 p.m. This is for your information and record. Thanking You, (As per BSE Announcement Dated on 07/03/2024)
27-Jan-2024	06-Feb-2024	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 6th February 2024 to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2023. This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 6th February, 2024 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-audited Financial Results of the Company for the quarter & nine months ended 31st December, 2023. 2. Appointed Mr. Sandip Somany (DIN 00053597) as an Independent Director with effect from 1st April, 2024 This is for your information and record. The Board of Directors of the Company has at its meeting held on 6th February, 2024 inter-alia considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2023. The Board of Directors of the Company has today i.e. 6th February, 2024 considered and approved the appointment of Mr. Sandip Somany (DIN:00053597) as an Independent Director for a term of 5 years from 1st April, 2024 to 31st March, 2029 subject to approval of shareholders. (As per BSE Announcement Dated on 06/02/2024)
20-Oct-2023	03-Nov-2023	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday 3rd November 2023 inter-alia to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2023. This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 3rd November, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter & half year ended 30th September, 2023, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter & half year ended 30th September, 2023, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.30 p.m. and ended at 5.45 p.m. (As Per BSE Announcement dated on 03.11.2023)
25-Jul-2023	04-Aug-2023	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday 4th August 2023 inter-alia to consider and approve the unaudited financial results for the quarter ended 30th June 2023. This is for your information and record. Thanking You This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th August, 2023 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-audited Financial Results of the company for the quarter ended 30th June, 2023. 2. Change in Directorship - Resignation by Director 3. Convening Annual General Meeting 4. Fixation of Record/Book Closure Dates The Board meeting commenced at 3.00 p.m. and ended at 5:15 p.m. we are enclosing hereby un-audited financial results for the quarter ended 30th June, 2023 along with a copy of the Limited Review Report by the Statutory Auditor of the Company. (As Per BSE Announcement dated on 04.08.2023)
11-May-2023	23-May-2023	Accounts	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 23rd May 2023 inter alia: - a) to consider and approve the audited financial results for the quarter/ year ended 31st March 2023; and b) to consider and recommend dividend if any on equity shares of the Company for the financial year 2022-23. This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. Pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m. We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders. (As per BSE Announcement Dated on 23/05/2023)
23-Jan-2023	08-Feb-2023	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday 8th February 2023 to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2022. This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m. (As Per BSE Announcement dated on 08.02.2023)
20-Oct-2022	04-Nov-2022	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday 4th November 2022 to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2022. This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th November, 2022 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter & half year ended 30th September, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter & half year ended 30th September, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.30 p.m. and ended at 5.25 p.m. (As Per BSE Announcement dated on 04.11.2022)
29-Jul-2022	08-Aug-2022	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2022 This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 8th August, 2022 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2022, along with the Limited Review Report of the statutory auditor. 2. Approved convening the thirty-fourth Annual General Meeting (AGM) of the Company, on Friday, 23rd September, 2022, through video conferencing and other audio visual means. 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 17th September, 2022 to Friday, 23rd September, 2022 (both days inclusive) for the purpose of the AGM and declaration of dividend. The Board meeting commenced at 3.00 p.m. and ended at 5.20 p.m. (As Per BSE Announcement Dated on 08.08.2022)
11-May-2022	20-May-2022	Quarterly Results	Indraprastha Medical Corporation Limited has informed the Exchange about Board Meeting to be held on 20-May-2022 to consider financial statements for the period ended March 2022 and Dividend 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and 3. Re-appointed, based on the recommendation of the Audit Committee, S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company. (As per BSE Announcement Dated on 20/05/2022)
29-Jan-2022	08-Feb-2022	Quarterly Results	INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 8th February 2022 inter-alia to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2021. This is for your information and record. The Board of Directors of the Company, at their meeting held on 8th February, 2022, have approved the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3.00 p.m. and ended at 5.55 p.m. (As per BSE Announcement Dated on 08/02/2022)
01-Nov-2021	09-Nov-2021	Quarterly Results	Quarterly Results INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 9th November, 2021, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2021. The Board of Directors of the Company, at their meeting held on 9th November, 2021, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2021, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3.00 p.m. and ended at 5.05 p.m. This is for your information and record. (As Per BSE Announcement dated on 09.11.2021)

1 2

LOGIN HERE

Indraprastha Medical Corporation Ltd

Board Meeting